Please log in to view this page
Username
Password
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
